Injectable botulinum toxin formulations

Details for Australian Patent Application No. 2009332947 (hide)

Owner Revance Therapeutics, Inc.

Inventors Ruegg, Curtis L.; Stone, Hongran F.; Waugh, Jacob M.

Agent Freehills

Pub. Number AU-A-2009332947

PCT Pub. Number WO2010/078242

Priority 61/142,063 31.12.08 US

Filing date 28 December 2009

Wipo publication date 8 July 2010

International Classifications

A61K 39/08 (2006.01) Medicinal preparations containing antigens or antibodies - Clostridium, e.g. Clostridium tetani

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/078242 Priority application(s): WO2010/078242

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009332948-Method and system for producing hydrocarbons from a hydrate reservoir using available waste heat

2009332945-Systems and methods for processing tissue samples for histopathology